NGF-TrkA轴通过miR-29b-3p抑制增强骨髓瘤中PDGF-C介导的血管生成:使用拉罗特雷克提尼布的潜在治疗策略

Sheng-Mou Hou1,2, Ching-Yuan Cheng3, Wei-Li Chen4

  • 1Department of Research, Taiwan Blood Services Foundation, Taipei 111, Taiwan.

Life (Basel, Switzerland)
|January 25, 2025
PubMed
概括

神经生长因子 (NGF) 通过上调PDGF-C和抑制miR-29b-3p促进骨髓瘤 (OS) 血管生成. TrkA抑制剂拉罗特雷克提尼布显示出治疗OS中NGF驱动的血管生成的潜力.